Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine and the sole member of the type II interferon class. Originally referred to as macrophage-activating factor, IFN-γ is now recognized as ...
T cells have long been studied for their ability to target and eliminate tumor cells. In order for the T cells to do so, the tumors must express antigens not presented by healthy tissues, and the ...
Stanford researchers identified a two-step immune process causing rare myocarditis after mRNA COVID-19 vaccines, primarily in ...
Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...
During a bout of influenza, B cells interact with other immune cells and then take different paths to defend the body. One path is the B cells that differentiate into lung-resident memory B cells, or ...
ACROBiosystems — the leading producer of recombinant proteins and other vital reagents to encourage the development of target therapeutics, diagnostics, and vaccines — has established an antibody ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
Wellbeing Whisper on MSN
Stanford study reveals immune trigger behind rare vaccine heart risk
Your body needs these cytokines to ward off viruses. It’s essential to immune response but can become toxic in large amounts,” said Dr. Joseph Wu, director of the Stanford Cardiovascular Institute.
Characterizing the tumor and immune landscape of melanoma patients treated with combined checkpoint blockade and MAPK targeted therapy. TMB and BRAF mutation status are independent predictive factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results